Basic Study
Copyright ©The Author(s) 2024.
World J Hepatol. Jan 27, 2024; 16(1): 75-90
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.75
Figure 3
Figure 3 Protein concentration of autophagy markers. A: Protein expression bands obtained through the Western blot technique; B: p62/SQSTM1 expression (densitometry analysis); C: MAP1LC3B expression (densitometry analysis). Data expressed as median (25th-75th percentile), Kruskal-Wallis test. Different letters indicate a significant difference between groups (P < 0.05). aP < 0.05, bP < 0.05. Different letters indicate a significant difference between groups. HCC: Hepatocellular carcinoma; MAP1LC3B: Autophagy-related factor LC3A/B, p62/SQSTM1: Sequestosome-1; RIF: Rifaximin.

  • Citation: Michalczuk MT, Longo L, Keingeski MB, Basso BS, Guerreiro GTS, Ferrari JT, Vargas JE, Oliveira CP, Uribe-Cruz C, Cerski CTS, Filippi-Chiela E, Álvares-da-Silva MR. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease. World J Hepatol 2024; 16(1): 75-90
  • URL: https://www.wjgnet.com/1948-5182/full/v16/i1/75.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v16.i1.75